经口手术联合吲哚菁绿前哨淋巴结导航治疗喉咽癌的多中心可行性研究
前哨淋巴结识别率100%,2年延迟颈淋巴结转移1例,准确率95.5%、灵敏度75%、特异度100%;5年疾病特异性生存100%、总生存72.3%、无病生存60.5%。结论认为该联合策略作为微创方案可行且肿瘤学结局良好。
要点
- TOS联合ICG-SNNS在喉咽癌中前哨淋巴结识别率达100%。
- 该策略2年延迟颈淋巴结转移率低,准确率95.5%、特异度100%。
- 5年疾病特异性生存100%,总生存72.3%,无病生存60.5%。
核心结论
- 经口手术联合ICG-SNNS作为喉咽癌微创策略可行,并获良好肿瘤学结局。
主要发现
- 1例出现延迟颈淋巴结转移;准确率95.5%,灵敏度75%,特异度100%。
- 5年疾病特异性生存100%,总生存72.3%,无病生存60.5%。
关键数值与推荐
- 前哨淋巴结识别率100%,准确率95.5%,灵敏度75%,特异度100%。
- 5年疾病特异性生存100%,总生存72.3%,无病生存60.5%。
临床怎么用
- 对临床T1/T2、N0期口咽、下咽或声门上癌,可考虑TOS联合ICG-SNNS以兼顾原发灶与淋巴结的微创处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sentinel node navigation surgery using indocyanine green (ICG-SNNS) can be performed in the operation room. The combination of minimally invasive transoral surgery (TOS) with ICG-SNNS can provide functional preservation options for both primary lesions and lymph node (LN) metastasis. This multicenter feasibility study of this strategy was conducted in Japan. METHODS: Patients with clinical T1 or T2, N0 oropharyngeal, hypopharyngeal, or supraglottic cancer were enrolled. The identification rate of sentinel nodes, delayed cervical LN metastasis in 2 years, and survival rate were assessed. RESULTS: Twenty-two patients (10 oropharynx, 8 hypopharynx, 4 supraglottic cancer) were enrolled. The identification rate was 100%. One case had delayed nodal metastasis. The accuracy was 95.5%, sensitivity was 75%, and specificity was 100%. The 5-year disease-specific survival was 100%, overall survival was 72.3%, and disease-free survival was 60.5%. CONCLUSIONS: The combination of TOS with ICG-SNNS is feasible as a minimally invasive strategy and has favorable oncological outcomes.
引用
- Araki K, Tomifuji M, Shiotani A, et al. Minimally invasive surgery for laryngopharyngeal cancer: Multicenter feasibility study of a combination strategy involving transoral surgery and real-time indocyanine green fluorescence-navigated sentinel node navigation surgery. Head Neck. 2019. PMID: 31670870. doi:10.1002/hed.25993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。